As with any medicine, the MHRA will keep the safety and effectiveness of seladelpar under close review.  The Medicines and ...
The Medicines and Healthcare products Regulatory Agency has approved the medicine seladelpar in adults for the treatment of a liver illness ...
GlobalData on MSN1d
FDA beats EMA to most approved new drugs in 2024The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs ...
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 ...
With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...
Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today, approved Livdelzi (seladelpar), developed by ...
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
The Dallas Cowboys' search for the franchise's next head coach is underway. On Monday, longtime Cowboys owner and general manager Jerry Jones confirmed that the organization and coach Mike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback